Wilmington Trust National Association’s AbbVie ABBV Stock Holding History

Wilmington Trust National Association’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$12.1M	Buy	214,054 +2,106	+1%	+$110K	0.42%	67
2014 Q1	$10.9M	Sell	211,948 -21,844	-9%	-$1.1M	0.4%	66
2013 Q4	$12.3M	Sell	233,792 -1,344	-0.6%	-$66.1K	0.45%	59
2013 Q3	$10.5M	Buy	235,136 +25,327	+12%	+$1.12M	0.42%	61
2013 Q2	$8.67M	Buy	+209,809	New	+$9.18M	0.38%	68

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wilmington Trust National Association's ABBV Position: Q2 2014 in Review

Wilmington Trust National Association increased its AbbVie (ABBV) stake by 0.99% in Q2 2014, buying an estimated $110K and bringing the position to 214,054 shares worth $12.1M. The position accounts for 0.42% of the portfolio, ranked #67.

Wilmington Trust National Association first reported a position in ABBV in Q2 2013 and has held it in 5 quarters since. The position peaked at $12.3M in Q4 2013. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

Wilmington Trust National Association held 214,054 shares of AbbVie worth $12.1M as of Q2 2014.
Wilmington Trust National Association bought 2,106 AbbVie shares in Q2 2014, an estimated $110K.
AbbVie made up 0.42% of Wilmington Trust National Association's portfolio in Q2 2014, its #67 holding.
Wilmington Trust National Association first reported a position in AbbVie in Q2 2013 and has held it in 5 quarters since.
Wilmington Trust National Association's AbbVie position peaked at $12.3M in Q4 2013.
1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Wilmington Trust National Association's 13F filing for Q2 2014, filed 13 Aug 2014.